Kezar Life Sciences's total assets for Q2 2025 were $109.12M, a decrease of -12.88% from the previous quarter. KZR total liabilities were $17.34M for the fiscal quarter, a -21.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.